Business Wire

Renowned French Sommeliers Appointed as Ambassadors for “Awasake,” a Sparkling Japanese Sake Exported to Over 25 Countries and Regions Throughout the World!

13.4.2021 12:00:00 EEST | Business Wire | Press release

Share

The Japan Awasake Association (Representative Director: Noriyoshi Nagai, President of Nagai Sake Inc.), an association established by brewers of sparkling Japanese sake “Awasake,” which is produced by combining traditional sake production methods with advanced technologies such as secondary fermentation in the bottle, held a press conference at the Kanze Noh Theater, a sanctuary of Japanese traditional culture, in Ginza, Tokyo, on Tuesday, March 9.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210413005529/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Brewers and others who participated in the press conference (Photo: Business Wire)

There are currently 27 brands of Awasake that have been certified through a strict screening process and comply with standards such as being clearly transparent, and having a ray of beautiful and fine bubbles through maturation. Of these, 20 varieties are exported to over 25 countries and regions throughout the world, including the United States, Australia, Hong Kong, and Singapore. In recent years, Awasake has attracted much attention for the rapid increase in the number of sake-related awards it has received overseas.

* March 9, media video of the Certification Ceremony and Appointment Ceremony:
https://www.youtube.com/watch?v=nit7UW1vibg&t=2700s

* List of exported Awasake and history of their awards throughout the world:
http://greencreate.boo.jp/PR/awa.pdf

* Online shopping website of Japanese sake for overseas:
https://japanpage.jp/en/awasake

At this press conference, Mr. Shinya Tasaki, President of the Japan Sommelier Association, highly praised the great compatibility between ‘Awasake’ and French cuisine. Also this year, Mr. Xavier Thuizat and Mr. Philippe Jamesse, both famous French sommeliers, were appointed as Awasake Ambassadors. Furthermore, an original Association Awasake glass supervised by Philippe Jamesse was also unveiled.

“We would like to promote the appeal of sparkling Japanese sake, which has a unique value distinct from champagne and is a world-class, high-value-added product. We would like to make Awasake the toast of the world," said the Association.

* Japan Awasake Association official website:
https://awasake.or.jp/en/

* Japan Awasake Association youtube channel:
https://www.youtube.com/channel/UCnMFNdgRoattkORlFCE2SHQ

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Japan Awasake Association
Public Relations: Tomoko Takiguchi
+81-80-8422-5844
info@greencreate.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye